32.80
0.08 (0.24%)
| Previous Close | 32.72 |
| Open | 32.72 |
| Volume | 200,154 |
| Avg. Volume (3M) | 584,589 |
| Market Cap | 19,301,584,896 |
| Price / Earnings (TTM) | 156.19 |
| Price / Earnings (Forward) | 48.78 |
| Price / Sales | 11.28 |
| Price / Book | 10.81 |
| 52 Weeks Range | |
| Earnings Date | 28 May 2025 |
| TTM Dividend Yield | 1.17% |
| Profit Margin | 9.44% |
| Operating Margin (TTM) | 22.93% |
| Diluted EPS (TTM) | 0.210 |
| Quarterly Revenue Growth (YOY) | 18.40% |
| Quarterly Earnings Growth (YOY) | 42.80% |
| Total Debt/Equity (MRQ) | 7.82% |
| Current Ratio (MRQ) | 2.06 |
| Operating Cash Flow (TTM) | 506.10 M |
| Levered Free Cash Flow (TTM) | 303.21 M |
| Return on Assets (TTM) | 10.85% |
| Return on Equity (TTM) | 9.70% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Medical Instruments & Supplies (AU) | Mixed | Mixed |
| Medical Instruments & Supplies (Global) | Bearish | Mixed | |
| Stock | F&P HEALTH FPO NZX [FPH] | - | - |
AIStockmoo Score
| Analyst Consensus | 0.0 |
| Insider Activity | NA |
| Price Volatility | 1.0 |
| Technical Moving Averages | 5.0 |
| Technical Oscillators | 4.0 |
| Average | 2.50 |
|
Fisher & Paykel Healthcare is one of the three largest respiratory care device companies globally. It is the market leader in hospital use humidifiers, masks and related consumables and the number three player in the at-home treatment of sleep apnea using respiratory devices. Both the hospital and homecare markets for respiratory devices are growing strongly in the developed markets in which Fisher & Paykel has a presence. The company earns 42% of its revenue in the US, 32% in Europe, 18% in Asia-Pacific and the remaining 8% in emerging markets. Fisher conducts its own R&D and has thousands of patents and pending applications. It manufactures in New Zealand and Mexico and has a multichannel distribution model. |
|
| Sector | Healthcare |
| Industry | Medical Instruments & Supplies |
| Investment Style | Large Growth |
| % Held by Insiders | 6.95% |
| % Held by Institutions | 35.65% |
No data within this time range.
No data within this time range.
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2025 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |